  TEVA <TEVIY> SELLS PROMEDICO SUBSIDIARY      NEW YORK, March 17 - Teva Pharmaceut Industri Ltd, base Israel, sold wholli own Promedico subsidiary, foreign investor four mln dlrs. 
    It book valu unit 2.2 mln dlrs. 
    Teva continu market Promedico product through wholli own subsidiary, Salomon, Levin Elstein Ltd.
